학술논문
A randomized, double-blind, placebo-controlled 12-week trial of infliximab in patients with juvenile-onset spondyloarthritis
Document Type
Article
Author
Source
In: Arthritis Research and Therapy . (Arthritis Research and Therapy, December 2022, 24(1))
Subject
Language
English
ISSN
14786362
14786354
14786354